Anti-BCMA-CD19 CAR-T cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-BCMA-CD19 CAR-T cell therapy, covering 2025-09-03 to 2025-09-03. Get the full timeline:
Most recent: Clinical Trial Update: Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease [Phase 2]